REstore Working Ability in RheumatoiD Arthritis

PHASE4UnknownINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

March 31, 2013

Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL

adalimumab

40mg sc. every two weeks for six months

Trial Locations (4)

33521

RECRUITING

Tampere University hospital, Rheumatology Centre, Tampere

96101

RECRUITING

Lappland Central Hospital, Rovaniemi

00029

RECRUITING

Helsinki University Central Hopsital, Helsinki

Unknown

RECRUITING

The Turku Universitry Central Hopsital, Turku

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

The Rheumatological Center of Helsinki

NETWORK

NCT01405326 - REstore Working Ability in RheumatoiD Arthritis | Biotech Hunter | Biotech Hunter